Poster presented at the 25th North American ISSX meeting on Synthesis and Characterization of the Human Metabolites of the Echinocandin Drug Rezafungin by Microbial Biotransformation.
Poster presented on Structural Identification and Synthesis of the Acyl Glucuronide of the Macrolide Mcl-1 Inhibitor AZD5991 at Drug Discovery Chemistry 2023.
Poster presented by Julia Shanu-Wilson on “Oxidized Metabolites and Unusual Conjugates of AZD9496 formed by microbial biotransformation” at the ISSX/MDO 2022 meeting in Seattle, September 2022.
Poster on “PolyCYPs: Biocatalytic Tools for the Optimisation of Drug Leads” presented at the RSC Chemistry Meets Biology Meeting in London, September 2022.
Poster presented by Liam Evans at Drug Discovery Chemistry 2022 on “Routes for Synthesis of Metabolites of Ruxolitinib and Epacadostat”, April 2022.
Stay up to date with the latest news from Hypha Discovery
Sign up for our quarterly newsletters and monthly "Metabolite Tales" blog
Ready to begin? Our scientists are available to talk through your requirements
Hypha Discovery is a UK-based CRO supporting pharmaceutical and agrochemical companies worldwide through the production of metabolites and new derivatives of drugs and agrochemicals in discovery and development.